Potential Mechanisms of Resistance to Microtubule Inhibitors
To access this article, please choose from the options below
Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital. M.K. is supported by grants and a Career Development Award from the National Health and Medical Research Council (NHMRC).Dr Kavallaris has no conflict of interest to declare. Drs Annereau and Barret are both employees of the Institut de Recherche Pierre Fabre, a private pharmaceutical company supporting the development of vinflunine.
PII: S0093-7754(08)00019-5
doi:10.1053/j.seminoncol.2008.01.006
© 2008 Elsevier Inc. All rights reserved.
